市場調查報告書
商品編碼
1458063
生物分析測試服務的全球市場規模、佔有率和成長分析:按工作流程、按測試 - 產業預測(2024-2031)Global Bioanalytical Testing Services Market Size, Share, Growth Analysis, By Workflow(Sample Preparation, and Sample Analysis), By Test(ADME, PK) - Industry Forecast 2024-2031 |
生物分析測試服務的全球市場規模預計在2022年達到24.2億美元,從2023年的27.8億美元成長到2031年85.1億美元,預測期內(2024-2031年)複合年成長率為15%。
生物分析測試服務市場旨在為製藥和生物技術公司提供可靠和精確的測試解決方案,以支持安全有效的藥物的開發。全球生物分析測試服務市場的主要促進因素是對藥物開發和監管核准服務的需求不斷成長。隨著製藥和生物技術領域的快速擴張,對可靠、準確的檢測服務的需求不斷增加。然而,全球生物分析測試服務市場面臨的主要挑戰是與這些服務相關的高成本。全球生物分析測試服務市場的一個主要障礙與分析方法和程序缺乏標準化有關。不同服務供應商所採用的方法和程序的差異可能會導致結果不一致以及所產生資料的不可靠性。儘管面臨這些挑戰,全球生物分析測試服務市場為服務供應商提供了許多機會。對個人化醫療和標靶治療的需求迅速成長,推動了對更專業、更量身定做的檢測服務的需求。
Global bioanalytical testing services market size was valued at USD 2.42 billion in 2022 and is poised to grow from USD 2.78 billion in 2023 to USD 8.51 billion by 2031, at a CAGR of 15 % during the forecast period (2024-2031).
The bioanalytical testing services market aims to deliver dependable and precise testing solutions to pharmaceutical and biotech firms, aiding them in the development of safe and efficacious drugs. The principal driver behind the global bioanalytical testing services market is the escalating demand for drug development and regulatory approval services. As the pharmaceutical and biotech sectors undergo rapid expansion, there is a growing requirement for trustworthy and accurate testing services. However, the primary challenge for the global bioanalytical testing services market is the high cost associated with these services. A significant hurdle in the global bioanalytical testing services market pertains to the lack of standardization in analytical methods and procedures. Divergence in the methodologies and procedures employed by various service providers may result in inconsistent outcomes, thereby jeopardizing the reliability of the generated data. Despite these challenges, the global bioanalytical testing services market presents several opportunities for service providers. The burgeoning demand for personalized medicine and targeted therapies is propelling the necessity for more specialized and tailored testing services.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bioanalytical Testing Services Market Segmental Analysis
The global bioanalytical testing services market is segmented based on workflow, test, and region. By workflow, the market is segmented into sample preparation, and sample analysis. By test, the market is segmented into ADME, PK, PD, bioavailability, bioequivalence, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Bioanalytical Testing Services Market
There is a rising demand for personalized medicine, and bioanalytical testing services are pivotal in the development and evaluation of personalized drugs. These tests are instrumental in assessing the efficacy of drugs on individual patients and assist in determining the most suitable treatment regimen for patients. For example, in 2021, Q^2 Solutions, a leading provider of clinical trials laboratory services globally, broadened its biomarker capabilities to bolster the clinical advancement of personalized medicine. This expansion encompassed the establishment of a cutting-edge flow cytometry laboratory in Scotland, UK.
Restraints in the Global Bioanalytical Testing Services Market
An important factor expected to hinder the growth of the bioanalytical testing services market is the scarcity of qualified individuals proficient in operating the sophisticated equipment essential for conducting bioanalytical tests. According to the US Bureau of Labor Statistics, by 2020, there are projected to be 18,580 vacancies in clinical laboratory science (CLS) programs across the nation. However, only approximately 5,000 students complete accredited CLS programs each year. This indicates that educational programs are producing less than one-third of the necessary trained professionals. Consequently, the adoption of new technologies and methodologies may encounter challenges, potentially constraining the market's future growth.
Market Trends of the Global Bioanalytical Testing Services Market
Pharmaceutical companies are progressively turning to third-party service providers to outsource bioanalytical testing services, aiming to cut costs, enhance efficiency, and concentrate on their core strengths. This outsourcing trend is anticipated to persist in the foreseeable future.